EUVIMEDEUVIMED entdecken
Crossref

Value of the Serum Dexamethasone Determination for the Diagnosis of Mild Autonomous Cortisol Secretion

Marta Araujo-Castro iD, Alejandro Cortés Gómez, Marta Rosillo, Argeme Rodríguez, Imanol Madrid, Eider Pascual-Corrales, Ana M García Cano iD

Clinical Endocrinology · 2026

DOI: 10.1111/cen.70065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology, 2026. Verfasst von Marta Araujo-Castro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. Hauptthemen laut MEDLINE: Dexamethasone, Hydrocortisone, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Instituto de Salud Carlos III (PI22/01525: Estimation of fracture risk using the FRAX scale and analysis of bone mineral density on CT in patients with nonfunc…, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To analyze the dexamethasone bioavailability in the 1mg‐dexamethasone suppression test (DST) in patients with adrenal incidentalomas (AIs) to assess the reliability of the DST for the diagnosis of mild autonomous cortisol secretion (MACS).

Methods

A prospective cross‐sectional study of 140 consecutive patients with AIs who underwent simultaneous testing of serum dexamethasone and cortisol levels after the DST. MACS diagnosis was based on a DST value > 1.8 µg/dL in absence of specific clinical data of Cushing's syndrome, and nonfunctioning adrenal incidentaloma (NFAIs) diagnosis was established when cortisol post‐DST was ≤ 1.8 µg/dL and no evidence of other adrenal hormonal hypersecretion. Serum dexamethasone was measured with liquid chromatography coupled to mass spectrometry (LC–MS/MS).

Results

We enrolled 89 patients with MACS and 51 patients with NFAIs. Patients with MACS had higher late‐nigh salivary cortisol and cortisol post‐DST levels and lower DHEAS and ACTH values than NFAIs. In addition, they were older, had a higher prevalence of hypertension, diabetes and bilateral and larger adrenal tumors than NFAIs. Considering the 3.3 nmol/L serum dexamethasone threshold, we found that only 3.6% ( n = 5) of the patients who underwent DST did not achieve proper serum dexamethasone levels during the DST. A weak positive correlation between age and serum dexamethasone levels ( r = 0.191, p = 0.024) was observed. In addition, patients with MACS, hypertension and dyslipidemia reached higher serum dexamethasone levels after DST than those without these comorbidities.

Conclusion

Up to 4% of the patients with MACS diagnosis based on a DST > 1.8 µg/dl do not achieve enough dexamethasone levels to suppress the hypothalamic pituitary adrenal axis, suggesting that the positive results in the DST were not related with autonomous cortisol secretion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneHydrocortisoneAdrenal Gland NeoplasmsHumansFemaleMiddle AgedMaleCross-Sectional StudiesProspective StudiesAgedAdultCushing Syndrome

Stichwörter der Autor:innen

adrenal incidentalomadexamethasone suppression testhypercortisolismmild autonomous cortisol secretionserum dexamethasone

Substanzen

DexamethasoneHydrocortisone

Autor:innen und Institutionen

  • Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain.
  • Biochemical Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.

ORCID-Profile: Marta Araujo-Castro, Ana M García Cano

Förderung

  • Instituto de Salud Carlos III (PI22/01525: Estimation of fracture risk using the FRAX scale and analysis of bone mineral density on CT in patients with nonfunc…
  • Instituto de Salud Carlos III

Zitieren

APA

Araujo-Castro, M., Cortés Gómez, A., Rosillo, M., Rodríguez, A., Madrid, I., Pascual-Corrales, E., & García Cano, A. M. (2026). Value of the Serum Dexamethasone Determination for the Diagnosis of Mild Autonomous Cortisol Secretion. Clinical Endocrinology. https://doi.org/10.1111/cen.70065

Vancouver

Araujo-Castro M, Cortés Gómez A, Rosillo M, Rodríguez A, Madrid I, Pascual-Corrales E, et al. Value of the Serum Dexamethasone Determination for the Diagnosis of Mild Autonomous Cortisol Secretion. Clinical Endocrinology. 2026. doi:10.1111/cen.70065

BibTeX
@article{AraujoCastro2026,
  author = {Araujo-Castro, Marta and Cortés Gómez, Alejandro and Rosillo, Marta and Rodríguez, Argeme and Madrid, Imanol and Pascual-Corrales, Eider and García Cano, Ana M},
  title = {Value of the Serum Dexamethasone Determination for the Diagnosis of Mild Autonomous Cortisol Secretion},
  journal = {Clinical Endocrinology},
  year = {2026},
  doi = {10.1111/cen.70065}
}
Kostenlos starten →